Enovis (STU:C520) Inventories, Finished Goods : €486 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Enovis Inventories, Finished Goods?

Enovis's quarterly finished goods declined from Sep. 2023 (€378 Mil) to Dec. 2023 (€373 Mil) but then increased from Dec. 2023 (€373 Mil) to Mar. 2024 (€486 Mil).

Enovis's annual finished goods increased from Dec. 2021 (€264 Mil) to Dec. 2022 (€337 Mil) and increased from Dec. 2022 (€337 Mil) to Dec. 2023 (€373 Mil).

Enovis Inventories, Finished Goods Historical Data

The historical data trend for Enovis's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovis Inventories, Finished Goods Chart

Enovis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

428.34

339.34

264.13

337.14

373.16

Enovis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															339.48	354.26	377.96	373.16	486.38

Enovis Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Enovis (STU:C520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovis Corp (STU:C520) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

ENOV:USA

Address

2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808

Website

https://www.enovis.com

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.

Enovis (STU:C520) Headlines

No Headlines